Department of Pharmaceuticals opens second call under ₹5,000 crore PRIP scheme
On 28 August 2026, the Department of Pharmaceuticals announced the second call for applications under the ₹5,000 crore Promotion of Research and Innovation in Pharma & MedTech (PRIP) scheme.
Summary
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, announced the second call for applications under the Promotion of Research and Innovation in Pharma & MedTech (PRIP) scheme on 28 August 2026. The scheme has an outlay of ₹5,000 crore and was launched in 2023 to strengthen pharma and MedTech R&D. Early-stage projects of startups and MSMEs at Technology Readiness Level (TRL) 1–3, aiming for up to TRL 5, can get up to ₹5 crore each. Later-stage projects at TRL 4–6 can get up to ₹100 crore each, limited to 35% of the approved project cost.
Key facts
- Scheme
- Promotion of Research and Innovation in Pharma & MedTech (PRIP)
- Ministry
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
- Outlay
- ₹5,000 crore; launched 2023
- Early stage
- TRL 1–3 to max TRL 5; up to ₹5 crore per project
- Later stage
- TRL 4–6; up to ₹100 crore, max 35% of project cost
Practice MCQs 3 questions
What is the financial outlay of the PRIP scheme for pharma and MedTech research?
Show answer
Correct answer: D — ₹5,000 crore
The PRIP scheme is administered by which ministry/department?
Show answer
Correct answer: A — Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
Consider the following statements about the PRIP scheme's second call (August 2026): 1. Early-stage projects of startups and MSMEs can receive up to ₹5 crore per project. 2. Later-stage projects can receive up to ₹100 crore, with no limit on the share of project cost. Which of the above is/are correct?
Show answer
Correct answer: A — 1 only